Wegovy weight loss for men: how it works, what to expect

Step 1: understanding what Wegovy does differently in men

Wegovy works by activating GLP-1 receptors in the brain and gut, dialling down hunger signals and making smaller portions feel satisfying. That mechanism is the same regardless of sex. What differs is the average outcome.

In the STEP 1 trial, published in the New England Journal of Medicine, men on semaglutide 2.4mg lost around 12% of their body weight on average over 68 weeks, compared with roughly 15% in women. The gap is real, but 12% of body weight still represents a significant clinical change, for a 100kg man, that's roughly 12kg. Researchers have proposed several reasons for the sex difference: men tend to carry more visceral fat (which is metabolically active but also somewhat responsive to GLP-1 medicines), and hormonal differences in appetite regulation may play a role. Neither explanation is definitive yet.

A question our prescribers hear most weeks is whether men should expect weaker results and whether a different dose applies. The answer to both is no, the licensed maintenance dose is 2.4mg for all adults, and the titration schedule doesn't change by sex. A man with a BMI of 32 and hypertension follows the same step-up as anyone else meeting eligibility criteria.

Body composition is worth noting too. Men typically lose a higher proportion of fat mass relative to lean mass compared with women, which may be relevant if preserving muscle matters to you, something worth discussing with your prescriber alongside a protein-adequate diet and resistance exercise.

Step 2: eligibility and what a prescriber is actually checking

Wegovy's UK licence covers adults with a BMI of 30 or above, or 27 to 29.9 alongside at least one weight-related condition such as hypertension, type 2 diabetes, high cholesterol or obstructive sleep apnoea, the last of which affects men at roughly twice the rate of women. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance.

For men specifically, a prescriber will typically consider a few things that come up more often in this group: testosterone levels (low testosterone and obesity are linked in a cycle that weight loss can sometimes help break, but this is a clinical conversation, not a straightforward protocol); existing cardiovascular risk, since men tend to accumulate it earlier; and alcohol intake, which can affect both GI tolerance and the liver. None of these is automatically disqualifying, but they all shape the clinical picture.

NICE's appraisal of semaglutide for weight management, TA875, is the framework NHS prescribers follow. Private prescribing follows the licensed indications from the SmPC. At nume, a GPhC-registered Independent Prescriber reads every consultation personally (no automated triage) before any prescription is issued. If you want to understand the eligibility criteria in detail, our page on accessing Wegovy walks through them.

Step 3: the practical experience (injecting, side effects, and fitting it into daily life

The injection itself is subcutaneous) into the skin of the abdomen, thigh or upper arm, once a week, on a day that suits your routine. The pen is pre-filled and pre-set to the current dose. Most men who are new to self-injection find the technique straightforward after the first couple of weeks. How to use Wegovy covers the practical steps in full.

Side effects are predominantly gastrointestinal (nausea, loose stools or constipation, reflux, and occasional fatigue) and they're most pronounced in the first few weeks of a new dose. They generally settle. Eating smaller meals, avoiding very fatty foods, and staying well hydrated all help. The NHS medicines page for semaglutide lists the full side-effect profile with guidance on when to seek medical help.

Wegovy does need to be kept refrigerated, in the fridge door works fine. Each pen covers four weekly injections at the same dose. Starting Wegovy covers storage and what to do if you miss a dose (short answer: follow the Patient Information Leaflet and ask your prescriber if you're unsure, timing matters).

Cost is a real consideration. Private Wegovy pricing in the UK has changed since Novo Nordisk adjusted its list price, context that page addresses honestly. At nume, one transparent price covers consultation, prescription, treatment and next-working-day delivery. Worth knowing before you compare providers.

What the evidence doesn't yet tell us, and why that matters

Most weight-loss trial populations have included more women than men, and subgroup analyses for men are often underpowered. The 12% average is a reasonable benchmark, but individual variation is wide. Factors like starting weight, age, adherence, diet quality and physical activity all shift outcomes more than sex does.

There's also genuine uncertainty around long-term use beyond two years, and what happens to weight after stopping. These aren't reasons to avoid treatment if it's clinically appropriate, they're reasons to have an honest conversation with a prescriber rather than treating any trial figure as a personal guarantee.

If you want to understand the broader semaglutide picture before making a decision, our semaglutide overview sets out how the medicine works and what the clinical programme showed. And if you're ready to discuss whether Wegovy is suitable for you, speak to our prescribers through a free consultation at our treatment page, same-day clinical review, no waiting list.